Vor Biopharma

Developer of therapeutics to treat acute myeloid leukemia

placeCambridge, Massachusetts, United States calendar_todayFounded 2019 groups133 employees language vorbio.com

Registered entities

Investor mix

12 investors on record; 1 has since exited.

Investor typeCountShare
Venture capital758%
Bank & private debt18%
Other / undisclosed433%
Coming soon